We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+17.9%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12.6B
AUM Growth
+$1.99B
Cap. Flow
-$290M
Cap. Flow %
-2.3%
Top 10 Hldgs %
21.14%
Holding
876
New
80
Increased
408
Reduced
263
Closed
68

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$146M
2
CRM icon
Salesforce
CRM
+$65.4M
3
MRK icon
Merck
MRK
+$57.9M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$50.8M
5
C icon
Citigroup
C
+$46.5M

Sector Composition

Rank Sector Weight
1 Healthcare 34.01%
2 Technology 22.68%
3 Consumer Discretionary 9.38%
4 Financials 7.85%
5 Communication Services 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BE icon
226
Bloom Energy
BE
$61B
$12.4M 0.1%
433,062
+42,447
+11% +$906K
NEM icon
227
Newmont
NEM
$101B
$12.4M 0.1%
207,192
-15,296
-7% -$943K
HOLI
228
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$12.4M 0.1%
844,237
-35,989
-4% -$452K
TCRR
229
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$12.2M 0.1%
+394,282
New +$9.97M
KLAC icon
230
KLA
KLAC
$236B
$12M 0.09%
461,690
+167,430
+57% +$3.9M
AMP icon
231
Ameriprise Financial
AMP
$48.1B
$11.9M 0.09%
61,477
+26,059
+74% +$4.66M
CNST
232
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$11.9M 0.09%
411,512
+22,192
+6% +$559K
CHRS icon
233
Coherus Oncology
CHRS
$227M
$11.8M 0.09%
680,857
-27,193
-4% -$484K
RF icon
234
Regions Financial
RF
$26.3B
$11.8M 0.09%
733,357
+411,937
+128% +$5.96M
CCI icon
235
Crown Castle
CCI
$33.4B
$11.8M 0.09%
73,976
-1,523
-2% -$247K
MCHP icon
236
Microchip Technology
MCHP
$40.7B
$11.7M 0.09%
168,716
+98,342
+140% +$6.12M
SLB icon
237
SLB Ltd
SLB
$72.6B
$11.6M 0.09%
532,942
+103,277
+24% +$1.95M
ARGX icon
238
argenx
ARGX
$54.6B
$11.4M 0.09%
38,777
-246
-0.6% -$67.6K
GH icon
239
Guardant Health
GH
$20.2B
$11.4M 0.09%
88,352
-3,986
-4% -$459K
CL icon
240
Colgate-Palmolive
CL
$73.3B
$11.4M 0.09%
132,797
+5,682
+4% +$470K
URI icon
241
United Rentals
URI
$66.5B
$11.1M 0.09%
48,052
+7,468
+18% +$1.58M
TWTR
242
DELISTED
Twitter, Inc.
TWTR
$11.1M 0.09%
204,005
+29,878
+17% +$1.43M
AXP icon
243
American Express
AXP
$228B
$10.9M 0.09%
90,160
-67,745
-43% -$7.5M
SLF icon
244
Sun Life Financial
SLF
$45.9B
$10.8M 0.09%
244,201
+164,169
+205% +$7.11M
CAT icon
245
Caterpillar
CAT
$373B
$10.8M 0.09%
59,469
-92,219
-61% -$15.6M
MCD icon
246
McDonald's
MCD
$191B
$10.8M 0.09%
50,442
-4,329
-8% -$941K
BDX icon
247
Becton Dickinson
BDX
$45.6B
$10.8M 0.09%
44,121
-7,139
-14% -$1.66M
HCA icon
248
HCA Healthcare
HCA
$85.7B
$10.7M 0.08%
64,755
+13,100
+25% +$1.92M
RCUS icon
249
Arcus Biosciences
RCUS
$3.55B
$10.6M 0.08%
409,006
-79,664
-16% -$1.93M
TROW icon
250
T. Rowe Price
TROW
$25.6B
$10.5M 0.08%
69,553
-9,183
-12% -$1.31M

Similar funds

Candriam SCA's Q4 2020 Portfolio in Review

As of Q4 2020, Candriam SCA held 876 positions worth $12.6B, up 19% from $10.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q4 2020 filing shows 80 new, 408 increased, 263 reduced and 68 closed positions. Its largest new stake was Salesforce: 269,070 shares worth $59.9M. The largest sale was Amazon, an estimated $76.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Candriam SCA's largest Q4 2020 buy was Salesforce: 269,070 shares worth $59.9M.
  • Candriam SCA added most to Apple in Q4 2020, an estimated $146M increase.
  • Candriam SCA's biggest Q4 2020 reduction was Amazon, cutting an estimated $76.3M.
  • Candriam SCA fully exited VIVINT SOLAR, INC. in Q4 2020, selling an estimated $35.6M.
  • Candriam SCA's ten largest holdings make up 21% of its $12.6B portfolio in Q4 2020.
  • Candriam SCA opened 80 new positions and closed 68 in Q4 2020.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $12.6B.

Based on Candriam SCA's 13F filing for Q4 2020, filed 22 Jan 2021.